Not an eMediNexus Member?
Women with a ductal carcinoma in situ (DCIS) diagnosis were found to have over 3-fold increased likelihood of dying from breast ...MORE
A favorable lifestyle was found to be associated with a reduced risk of breast cancer even among women with high genetic risk fo ...MORE
Circulating levels of progesterone may have a role in predicting future breast cancer incidence in older women, suggests new res ...MORE
The U.S. Food and Drug Administration has provided accelerated approval to sacituzumab govitecan-hziy for the treatment of adult ...MORE
The FDA has approved tucatinib for treating advanced, HER2-positive breast cancer patients who have received at least one prior ...MORE
Anthracycline and trastuzumab therapy does not appear to be so cardiotoxic in women with breast cancer who are on statins, sugge ...MORE